✦ LIBER ✦

ED2 LONG-TERM COST-UTILITY ANALYSIS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN INTYPE 2 DIABETES PATIENTS IN THE GERMAN SETTING

✍ Scribed by G Goodall; WJ Valentine; C Townsend; R Kotchie; S Nielsen; K Erny-Albrecht

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB22 EVALUATING THE LONG-TERM COST-EFFE

✍ K Erny-Albrecht; G Goodall; C Townsend; R Kotchie; S Nielsen; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB63 ESTIMATING THE LONG-TERM CLINICAL

✍ K Erny-Albrecht; G Goodall; S Nielsen; C Townsend; R Kotchie; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PDB22 LONG-TERM COST-EFFECTIVENESS OF IN

✍ ME Minshall; NS Twena; L Nicklasson; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PDB47 LONG-TERM ECONOMIC OUTCOMES ASSOCI

✍ WJ Valentine; G Goodall; C Townsend; R Kotchie; S Nielsen; K Erny-Albrecht 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Cost-Effectiveness Of Therapy Conversion

✍ Xu, Z.R.; Ye, Q.; Zhang, YZ 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PDB23 COST-EFFECTIVENESS OF BIPHASIC INS

✍ M Aristides; R Kotchie; S Nielsen; C Townsend; WJ Valentine; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB